ORIGINAL ARTICLE
Linda Björkhem-Bergmana,b, Torbjörn Schultzb and Peter Strangb,c
aDepartment of Neurobiology, Care Sciences and Society (NVS), Division of Clinical Geriatrics, Karolinska Institutet, Huddinge, Sweden; bPalliative Medicine, Stockholms Sjukhem, Stockholm, Sweden; cDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden
Background: The immune system declines with age, but the impact of chronological age may be affected by sex, co-morbidities, and sociodemographic factors.
Objective: The article aims to study infections associated with hospital admission in the elderly in their last year of life and the impact of age, sex, co-morbidities, and sociodemographic factors.
Method: A retrospective study based on registry data covering all care visits in Stockholm Region, Sweden, for 7 years was conducted. All deceased subjects with at least one hospital admission with infection as the main diagnosis in the last year of life were compared with subjects with no such admission. Subjects were categorized into three different age-groups 65–79, 80–89, and 90 years and above. Co-morbidity was measured by the Charlson Comorbidity Index (CCI) and sociodemographic factors were assessed using the ‘Mosaic-system’. Subjects living in nursing homes were analyzed separately. Uni- and multivariable logistic regressions were conducted.
Results: Of the 55,238 subjects in the study population, 14,192 (26%) had at least one hospital admission due to infection in the last year of life. The risk of having a severe infection increased with age, adjusted odds ratio (OR): 1.30 (1.25–1.36), and 1.60 (1.52–1.69) for the age-groups 80–89 and ≥ 90 compared to the age-group 65–79. The most important factor for infection was a high co-morbidity score; adjusted OR: 1.75 (1.68–1.82). Male sex and living in a less affluent area were weaker risk factors for infections.
Conclusion: Chronological age and co-morbidities are independent risk factors of infections associated with hospital admission in the last year in life while male sex and sociodemographic factors have less impact.
KEYWORDS
Elderly; age; aging; infections; co-morbidities; frailty; sex-and-gender; immunity; sociodemographic factors
Citation: UPSALA JOURNAL OF MEDICAL SCIENCES 2024, 129, e10504
http://dx.doi.org/10.48101/ujms.v129.10504
Copyright: © 2024 The Author(s). Published by Upsala Medical Society.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Received 9 January 2024; Revised: 19 February 2024; Accepted: 20 February 2024; Published: 13 March 2024
Competing interests and funding: The authors declare that they have no competing interests.
Supplemental data for this article can be accessed here.
CONTACT Linda Björkhem-Bergman linda.bjorkhem-bergman@ki.se
It is well-known that the immune system declines with age. Older individuals are more susceptible to infections and often become more ill from various infections. The reason behind this is not fully understood but many believe that this has to do with an impaired immune response over time. That elderly have a weaker immune response to new viral infections became very clear during the COVID-19 pandemic, where age was the strongest risk factor for becoming seriously ill or dying from the disease (1). New studies indicate that the elderly also respond less well to COVID-19 vaccination, which is believed to be partly related to the fact that antibodies are not produced as efficiently (2).
Even before the pandemic, we knew that an outdated immune response against, for example, influenza has important consequences as this can lead to bacterial superinfection and an increased risk of dying from, for example cardiovascular diseases (3).
However, it seems that some older individuals have a better ability than others to create an effective immune response against different forms of infections. This has raised the question of why and in what way the immune system deteriorates in the elderly – and whether it is directly linked to chronological age or whether other factors such as co-morbidities and frailty are more important.
Frailty is a state of accelerated biological aging where the body gradually loses its ability to adapt to physical, psychological, and social stressors (4, 5). Both comorbidity, as measured by Charlson Comorbidity Index (CCI) (6) and frailty, as measured by the ICD-10-based Hospital Frailty Risk Score (HFRS), were independently associated with COVID-19 deaths in cancer (7).
During the COVID-19 pandemic it was evident that male sex was a strong risk factor for severe illness and death as a result of COVID-19 compared to being female (6, 8). Interestingly, females seem to also have a better outcome for other viral and bacterial infections (9, 10). Previous studies have shown that both the innate and adaptive immune responses are generally stronger in females than males and that females also have a better response to vaccinations (11). As a consequence, females are also more susceptible to inflammatory and autoimmune diseases (11).
The aim of the present study was to map the prevalence of severe infections leading to hospital admission in the last year before death in the elderly in different age-groups from 65 years and above and evaluate possible sex-differences. More specifically, we wanted to test the hypothesis that the risk of having a severe infection in end-of-life increases with higher chronological age, independently of co-morbidity and sociodemographic factors, and that men have a higher risk of severe infections compared to women. To this end, we conducted a population-based study on all deceased individuals in the Stockholm area over 7 years with the possibility to study age- and sex-differences, adjusted for sociodemographic factors and co-morbidities.
This was a retrospective study based on registry data from the administrative VAL database of the Stockholm’s region’s central data warehouse. Each clinic and care unit in Region Stockholm must report each patient visit to the VAL database and their pay from the Region (formerly: county council) is based on this data. Thus, the data are close to complete with few missing values.
In order to study infections leading to hospital admission in the elderly in the last year of life, data were collected for all deceased individuals 65 year of age or above during 2015–2021 living in the county of Stockholm, an area with approximately 2.3 million inhabitants. Subjects living in nursing homes were excluded from the main cohort since it is a population with special needs and where the treatments of infections may also be different. In the nursing homes, the residents have easier access to nurses and physicians and some infectious treatments can be imparted in the nursing home – without admission to the hospital. Thus, nursing home residents were analyzed separately.
The outcome measures were infections as the main diagnosis for hospital admission at any time during the least year of life. This was defined as having at least one episode of the following International Statistical Classification of Disease version 10 (ICD-10) codes as main diagnoses for the hospital admission: A00-A99 (excluding A81.0 and A81.2), B00-B89 (excluding B18), B99, G00-G07, H00.0, H60.0, H60.3, H66, H70, I00-I01, I30.1, J00-J06, J09-J18, J20-J22, J32, J34.0, J36, J40-J42, J44, J85-J86, K57, K61, K63.0, K65.0, L00-L08, L97, M00, M46.3, M46.5, M86, N10, N13.6, N15, N30 (excluding N30.4), N34.0, N34.1, N41.0, N41.2, N41.3, N45, N70, N71.1, N76.8, N76.4, N76.0, T81.4, T82.7, T83.5, T83.6, T84.5, T84.6, and T84.7. The outcome was binary: yes or no. For explanations of the ICD-codes see Supplementary file 1.
We did not include cases with Covid-19, that is ICD-code U07.1 och U07.2 since the aim was not to study how age affected the outcome in Covid-19. However, since the pandemic probably affected the frequency of admissions to hospitals in general, we also calculated the frequency for each year and the years during the Covid-19 pandemic (2020 and 2021) was compared with the non-pandemic years (2015–2019).
A separate analysis was conducted for nursing home residents. In addition, a separate analysis of the main cohort in the last 3 months in life was conducted.
In order to study the infection burden in the different age groups the cohort was divided into the age-groups of 65–79, 80–89, and 90 years or above. Since 65 years old is the threshold for being allowed for geriatric care in Sweden, we choose this threshold. Possible confounding factors were collected and adjusted for. This included sex, sociodemographic index measured by mosaic described further, and comorbidities measured by CCI. Both uni- and multivariable analyses were performed.
In order to study sex differences, the same analyses were performed but divided into men and women separately.
Charlson Comorbidity Index is a ICD-10 based construct and a measure of comorbidity. CCI is based on 19 ICD-10 diagnostic codes, where different codes add between 1 and 6 points to the index (12). A score of 0–2 is assessed as a low degree of co-morbidity and above 2 as a high burden of co-morbidities. Infections are not part of the score and thus CCI was assessed as suitable for this study, as it was strongly associated with COVID-19-related cancer deaths in a recent study (6).
In register data covering large populations, data on frailty measured with the widely used clinical frailty score (CFS) is not accessible (13). Instead, other tools for assessment of frailty, based on ICD-10 codes, such as HFRS have been developed (14). Since HFRS also includes infections as part of its score, that is infections add scores to the severity of frailty, we assessed that this tool, after pilot testing, was less suitable to use in the present study. Thus, we only used the CCI index in this study, as a proxy for frailty, although frailty and comorbidity are different constructs (12).
Mosaic is a system that divides a county or city into different groups of socioeconomic areas and can be used for studies where sociodemographic factors may have an impact (15, 16). It showed to be predictive during the first wave of the COVID-19 pandemic (16). Mosaic is based on information of median income, education, lifestyle, and living arrangements in a specific living area. The Stockholm Region is divided into 1,300 small areas (containing 1,500–1,800 inhabitants), and each area is classified as Mosaic 1, 2, or 3, where Group 1 corresponds to the most affluent areas. In the current study, we merged the group Mosaic 1 and 2 (affluent and middle-class areas) and compared them with Mosaic 3, that is less affluent areas.
Descriptive statistics are presented as means and standard deviations (SD). Differences between groups were assessed using Chi2-test for categorical variables and t-test for continues variables. Univariable logistic regression analysis were followed by multivariable logistic regressions models. For the comparison between different age-groups, adjustments were made for sex, CCI, and Mosaic. For the comparison between men and women, adjustments were made for age-groups, CCI, and Mosaic. Odds ratios (OR) were calculated, with 95% Confidence Intervals (CI) for each comparison.
In the logistic regression models, the youngest age-group, being women, and belonging to the highest sociodemographic group, that is Mosaic group 1–2 and having the ‘healthiest’ CCI-index, that is CCI 0-2, were chosen as reference groups.
As a measure of goodness of fit for binary outcomes in our multiple logistic regression models, we calculated C-statistic (equivalent to the area under the receiver operating characteristic curve). A C-statistic value of 0.5 indicates that the model is no better than chance at making a prediction of membership in a group and a value of 1.0 indicates that the model perfectly identifies those within a group and those not.
This study was approved by a decision of the Regional Ethical Review Board in Stockholm 2017 approving that all data from the VAL database on deceased patients were approved to be used for research studies (Dnr 2017/1141-31). All data were pseudonymized before analysis.
No written informed consent could be obtained since only deceased patients were included.
In the VAL-database, 97,708 deceased patients 65 years or older were identified in the Stockholm Region between 2015 and 2021 of which 55,238 had been living at home and 42,425 had been living in nursing homes at some time-point during the last year of life.
The study population for the main analysis was thus 55,283, 25,810 women, and 29,473 men. The median age was 82 years (range: 65–107). The demographic data of the study population are presented in Table 1. Women were generally older in the last year of life; they had fewer co-morbidities and were living in less-affluent areas compared to men (Table 1). In the study population, 14,192 (26%) persons had at least one hospital admission during their last year of life. The most common infections leading to hospital admission were pneumonia (ICD-codes: J189 and J159) which constituted 30% of all infections. Exacerbation of Chronic Obstructive Pulmonary Disorder (COPD, ICD-codes: J44.1 and J44.9) amounted for 16%, whereas sepsis (ICD-code A419) and tubulointerstitial nephritis (ICD-code N10.9) constituted 5% each.
The risk of having an infection leading to hospital admission increased with age and chronological age was also a significant risk factor after adjustments were made for co-morbidity, sex, and sociodemographic factors (Table 2). However, the strongest risk-factor for infection was co-morbidity as measured by CCI, both in the uni- and multivariable analyses. Living in a less affluent area was also a risk factor for infections both in the uni- and multivariable analyses, although the impact of this variable was less pronounced. Male sex showed a weak, but statistically significant, association with risk of infections in the adjusted model. When women and men were analyzed separately the same pattern appeared, that is chronological age and co-morbidity were independent risk factors in both men and women (data not shown).
Variable | n | Univariable analysis | Multivariable analysis* | ||
OR (95% CI) | P | OR (95% CI) | P | ||
Sex | |||||
Women | 25,810 | Ref. | Ref. | ||
Men | 29,473 | 1.03 (0.99–1.07) | 0.21 | 1.05 (1.01–1.09) | 0.03 |
Age groups 65–79 years 80–89 years 90 years or more |
26,672 19,100 9,511 |
Ref. 1.29 (1.24–1.35) 1.49 (1.41–1.57) |
< 0.001 < 0.001 |
Ref. 1.30 (1.25–1.36) 1.60 (1.52–1.69) |
< 0.001 < 0.001 |
Co-morbidity CCI 0–2 CCI > 2 |
22,332 32,951 |
Ref. 1.70 (1.63–1.77) |
< 0.001 |
Ref. 1.75 (1.68–1.82) |
< 0.001 |
Sociodemographic area Mosaic 1–2 Mosaic 3 |
35,155 20,128 |
Ref. 1.05 (1.01–1.09) |
0.03 |
Ref. 1.07 (1.02–1.11) |
0.03 |
Mosaic 3 = less affluent area, *c statistic was 0.59. |
Next, hospital admissions due to infections during the last 3 months in life were analyzed separately. A similar pattern appeared, that is older age and a high co-morbidity index were significantly associated with higher risk of hospitalization due to infections (data not shown). Being male and living in a less affluent area was also associated with a slightly increased risk of hospitalizations due to infections.
A separate analysis was also conducted in nursing homes residents since this group of elderly differs from those living at home. In line with the main analysis, a high co-morbidity index was an independent risk factor for infections that required hospitalization (Table 3). However, increasing age was a significant factor for not being admitted to hospital for infections. In addition, male sex was significantly associated with hospital admission due to infections, while sociodemographic factors were not.
Variable | n | Univariable analysis | Multivariable analysis* | ||
OR (95% CI) | P | OR (95% CI) | P | ||
Sex | |||||
Women Men |
26,055 16,370 |
Ref. 1.86 (1.78–1.95) |
< 0.001 |
Ref. 1.53 (1.45–1.60) |
< 0.001 |
Age groups 65–79 years 80–89 years 90 years or more |
7,101 16,963 18,361 |
Ref. 0.81 (0.77–0.87) 0.55 (0.52–0.59) |
< 0.001 < 0.001 |
Ref. 0.88 (0.82–0.94) 0.70 (0.66–0.75) |
< 0.001 < 0.001 |
Co-morbidity CCI 0–2 CCI > 2 |
26,675 15,750 |
Ref. 3.01 (2.95–3.23) |
< 0.001 |
Ref. 2.82 (2.69–2.95) |
< 0.001 |
Sociodemograpic area Mosaic 1–2 Mosaic 3 |
27,349 15,076 |
Ref. 1.04 (0.99–1.09) |
0.15 |
Ref. 1.01 (0.96–1.06) |
0.66 |
Mosaic 3 = less affluent area, *c statistic was 0.58. |
Since the COVID-19 pandemic might influence the hospital admissions during 2020 and 2021 we conducted a separate analysis to study differences between the years. There was a significant decrease in number of hospital admissions due to infections in 2020 (25%) and in 2021 (23%) compared to 2015–2019 (27%) (P < 0.01). For nursing homes residents, the decrease was even more pronounced, in 2020 (18%) and 2021 (22%) compared to 2015–2019 (25%) (P < 0.001).
In this study, we could confirm our hypothesis that high chronological age is an independent risk factor for having an infection leading to hospital admission in the last year in life. However, co-morbidity was the strongest independent risk factor for having infections that required hospitalization. Adjustment for sociodemographic factors and sex did not affect the risk. Still, the increased risk for infections in relation to age and co-morbidities can be considered as only moderate as judged by the OR values and the goodness of fit statistics, that is the c-statistic values.
Previous studies have shown that elderly persons are generally more susceptible to infections and often have poorer outcomes of infections compared to younger individuals (1, 2, 17). Interestingly, our results also show that chronological age is an independent risk factor, also when adjustment was made for co-morbidities. This strengthens the hypothesis that the immune function deteriorates with age – regardless of other factors. Our results further strengthen the fact that there is also a gradient of impairment with chronological age from 65 years and above.
We could also confirm previous results showing that a high CCI index, score 3 and above, is an independent risk factor for infections and poorer outcome (6, 18).
Studies during the COVID-pandemic showed that male sex was an independent risk factor for having a more severe infection or to die from the disease (6, 8). In addition, other studies have shown that men have a higher risk of infections (9–11). Our results show that being male was a weak risk factor for hospital admission due to infections during the last year in life for people living in their own homes. However, for people living in nursing homes, male sex was an independent and important risk factor for being admitted to acute hospitals due to infections, regardless of age, co-morbidity, and sociodemographic factors. However, this is not necessarily a measure of a higher susceptibility to infections but might reflect a general tendency to admit male nursing home residents to acute hospitals, despite similar conditions. This was also recently shown in a cohort of more than 30,000 nursing home residents (19).
In this study, sociodemographic factors measured with Mosaic had some impact on the risk of having an infection – but other factors were more important. This is in contrast to previous studies on COVID-infections in the same population (Region Stockholm) where living in less-affluent areas was an important risk factor for severe infections and death as a result of COVID-19 (16). This might be explained by the fact that people living in these areas were the most unprotected from COVID-19 when vaccines and protective equipment were missing during the first year of the pandemic. They were taxi drivers, bus drivers, workers in restaurants and in places where they were generally more exposed to the COVID-19 virus than people living in affluent and middle-class areas.
The number of hospital admissions due to infections (except for COVID-19) decreased during the pandemic, 2020 and 2021. During these years most people, especially elderly, avoided going to the hospital and the emergency departments due to restrictions. The findings with a pronounced reduced number of admissions due to infections among nursing home residents during the pandemic years are in line with clarified national recommendations regarding prioritizing intensive care under extraordinary conditions (20). In summary, the importance of considering biological age and its impact on patient benefit to ensure that the strained resources were used for the patients who were expected to benefit the most.
We also studied data for the last 3 months in life separately in order to evaluate if there were factors that were especially important during the last months in life. In the 3-month data, co-morbidity and high chronological age were also the most important risk factors for hospital admission, as in the main analysis.
Notably, the data from nursing homes showed a completely opposite pattern regarding age where younger age was associated with hospital admission due to infection. We cannot explain these findings, but it indicates that there is an inequality between younger and older residents at nursing homes, where nursing home care is supplemented with hospital care to a greater degree for younger residents. However, further investigations are needed before firm conclusions can be drawn.
The data in this study cover the whole population of deceased subjects 65 years and older in the Stockholm region. Although there might be regional differences, we think that the results might be generalizable for elderly in Sweden and in other countries as well with similar socioeconomics.
The major strength of this study is that we have a large cohort with consecutive data, with almost no missing data.
A limitation is that we only know that the subjects were admitted to hospital due to infections, but not the outcome of the infections. For example, we cannot know whether men had longer hospital stays or died more frequently due to infections – only that they were treated more often. Another limitation is that we could not study how frailty affected the risk of infections since all frailty tools developed for registry data comprise infections as a variable. Notably, we attempted to use the HFRS-score (14) but after pilot-testing we assessed this as a less suitable tool for this study, although HFRS-score was a highly significant variable in univariable comparisons (data not shown). Although co-morbidity co-variates with frailty to some extent – prognostic tools developed specifically for frailty seem to be more sensitive than CCI (21, 22).
To conclude, this study shows that chronological age and having a high co-morbidity index were independent risk factors for having an infection leading to hospital admission during the last year of life.
This study was supported by grants from The Swedish Cancer (LBB; CAN2018/316), The Swedish Research Council (LBB: 2022-00651), and Stockholm County Council (LBB FoUI-974833). The aggregated data are available from the corresponding author on request.
LBB, TS, and PS designed the study. TS and PS collected the data and LBB, TS, and PS analyzed the data. LBB wrote the first draft of the manuscript. LBB, TS, and PS reviewed and revised the manuscript and have read and approved the final version.
Linda Björkhem-Bergman https://orcid.org/0000-0003-3505-9283
Torbjörn Schultz https://orcid.org/0000-0003-1619-4965
Peter Strang https://orcid.org/0000-0001-8514-5433
1. | Romero Starke K, Reissig D, Petereit-Haack G, Schmauder S, Nienhaus A, Seidler A. The isolated effect of age on the risk of COVID-19 severe outcomes: a systematic review with meta-analysis. BMJ Glob Health. 2021;6(12):e006434. doi: 10.1136/bmjgh-2021-006434 |
2. | Kawasuji H, Morinaga Y, Tani H, Saga Y, Kaneda M, Murai Y, et al. Age-dependent reduction in neutralization against alpha and beta variants of BNT162b2 SARS-CoV-2 vaccine-induced immunity. Microbiol Spectr. 2021;9(3):e0056121. doi: 10.1128/Spectrum.00561-21 |
3. | Macias AE, McElhaney JE, Chaves SS, Nealon J, Nunes MC, Samson SI, et al. The disease burden of influenza beyond respiratory illness. Vaccine. 2021;39 Suppl 1:A6–14. doi: 10.1016/j.vaccine.2020.09.048 |
4. | Falk Erhag H, Guethnadottir G, Alfredsson J, Cederholm T, Ekerstad N, Religa D, et al. The association between the clinical frailty scale and adverse health outcomes in older adults in acute clinical settings – a systematic review of the literature. Clin Interv Aging. 2023;18:249–61. doi: 10.2147/CIA.S388160 |
5. | Rohrmann S. Epidemiology of frailty in older people. Adv Exp Med Biol. 2020;1216:21–7. doi: 10.1007/978-3-030-33330-0_3 |
6. | Strang P, Hedman C, Adlitzer H, Schultz T. Dying from cancer with COVID-19: age, sex, socio-economic status, and comorbidities. Acta Oncol. 2021;60(8):1019–24. doi: 10.1080/0284186X.2021.1934536 |
7. | Strang P, Schultz T. Dying with cancer and COVID-19, with special reference to lung cancer: frailty as a risk factor. Cancers (Basel). 2022;14(23). doi: 10.3390/cancers14236002 |
8. | Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, et al. Risk factors associated with mortality among patients with COVID-19 in intensive care units in Lombardy, Italy. JAMA Intern Med. 2020;180(10):1345–55. doi: 10.1001/jamainternmed.2020.3539 |
9. | Dias SP, Brouwer MC, van de Beek D. Sex and gender differences in bacterial infections. Infect Immun. 2022;90(10):e0028322. doi: 10.1128/iai.00283-22 |
10. | Jacobsen H, Klein SL. Sex differences in immunity to viral infections. Front Immunol. 2021;12:720952. doi: 10.3389/fimmu.2021.720952 |
11. | Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626–38. doi: 10.1038/nri.2016.90 |
12. | Charlson ME, Carrozzino D, Guidi J, Patierno C. Charlson comorbidity index: a critical review of clinimetric properties. Psychother Psychosom. 2022;91(1):8–35. doi: 10.1159/000521288 |
13. | Church S, Rogers E, Rockwood K, Theou O. A scoping review of the Clinical Frailty Scale. BMC Geriatr. 2020;20(1):393. doi: 10.1186/s12877-020-01801-7 |
14. | Gilbert T, Neuburger J, Kraindler J, Keeble E, Smith P, Ariti C, et al. Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study. Lancet. 2018;391(10132):1775–82. doi: 10.1016/S0140-6736(18)30668-8 |
15. | Dahlen E, Komen J, Jonsson EW, Almqvist C, Kull I, Wettermark B. Eliminated patient fee and changes in dispensing patterns of asthma medication in children – an interrupted time series analysis. Basic Clin Pharmacol Toxicol. 2019;125(4):360–9. doi: 10.1111/bcpt.13268 |
16. | Strang P, Furst P, Schultz T. Excess deaths from COVID-19 correlate with age and socio-economic status. A database study in the Stockholm region. Ups J Med Sci. 2020;125(4):297–304. doi: 10.1080/03009734.2020.1828513 |
17. | Humbert M, Olofsson A, Wullimann D, Niessl J, Hodcroft EB, Cai C, et al. Functional SARS-CoV-2 cross-reactive CD4(+) T cells established in early childhood decline with age. Proc Natl Acad Sci U S A. 2023;120(12):e2220320120. doi: 10.1073/pnas.2220320120 |
18. | Tuty Kuswardhani RA, Henrina J, Pranata R, Anthonius Lim M, Lawrensia S, Suastika K. Charlson comorbidity index and a composite of poor outcomes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Metab Syndr. 2020;14(6):2103–9. doi: 10.1016/j.dsx.2020.10.022 |
19. | Salaj D, Schultz T, Strang P. Nursing home residents with dementia at end of life: emergency department visits, hospitalizations, and acute hospital deaths. J Palliat Med. 2023. doi: 10.1089/jpm.2023.0201 |
20. | Socialstyrelsen: Nationella principer för prioritering inom intensivvård under extraordinära förhållanden (Swe: National Principles for Prioritization in Intensive Care Units under Extraordinary Conditions). National Board of Health and Welfare (Socialstyrelsen); 2020. Available from: https://www.socialstyrelsen.se/globalassets/sharepoint-dokument/artikelkatalog/foreskrifter-och-allmanna-rad/2014-5-19.pdf [cited March 2024] |
21. | Elsamadicy AA, Havlik JL, Reeves B, Sherman J, Koo AB, Pennington Z, et al. Assessment of frailty indices and Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases: a national database analysis. World Neurosurg. 2022;164:e1058–70. doi: 10.1016/j.wneu.2022.05.101 |
22. | Hersh AM, Pennington Z, Hung B, Patel J, Goldsborough E, Schilling A, et al. Comparison of frailty metrics and the Charlson Comorbidity Index for predicting adverse outcomes in patients undergoing surgery for spine metastases. J Neurosurg Spine. 2021:1–9. |